教員情報 - 浅野　澄恵

（最終更新日：2021-09-12 18:18:32）

  アサノ　スミエ
  浅野　澄恵
   所属   川崎医科大学医学部臨床医学　リウマチ・膠原病学

職種講師

■ 学術雑誌

1.	2021/04/17	原著	SH3BP2 Deficiency Ameliorates Murine Systemic Lupus Erythematosus.
2.	2021/01/26	原著	Deletion of Mir223 exacerbates lupus nephritis by targeting S1pr1 in Faslpr/lpr mice
3.	2020/06	原著	Association of Explanatory Histological Findings and Urinary Protein and Serum Creatinine Levels at Renal Biopsy in Lupus Nephritis: A Cross-Sectional Study
4.	2020/02/29	原著	Damage accrual related to pregnancies before and after diagnosis of systemic lupus erythematosus: a cross-sectional and nested case-control analysis from a lupus registry.
5.	2019/09	原著	Cluster Analysis Using Anti-Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis.
6.	2019/07/18	原著	Thrombocytosis as a prognostic factor in polymyalgia rheumatica: characteristics determined from cluster analysis.
7.	2019/07/10	原著	Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
8.	2019/06/14	症例報告	Capnocytophaga canimorsus peritonitis diagnosed by mass spectrometry in a diabetic patient undergoing peritoneal dialysis: a case report.
9.	2019/06	原著	Inflammatory myopathy associated with PD-1 inhibitors.
10.	2019/02/28	原著	Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice derived CD4+ T cells.
11.	2018/11	原著	Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
12.	2018/10/04	原著	An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin.
13.	2018/07	症例報告	Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab.
14.	2018/07	原著	Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
15.	2018/01	原著	Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositis.
16.	2017/09	症例報告	Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF Therapy.
17.	2017/09	原著	Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
18.	2017/07	原著	Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
19.	2017/06/01	原著	Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.
20.	2017/05	原著	A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy.
21.	2017/05	原著	Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice.
22.	2017/05	原著	LXR, PPARγ, and PPARδ agonists are not sufficient to demonstrate therapeutic potential against mouse model of systemic lupus erythematosus.
23.	2016	症例報告	Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.
24.	2012/09	原著	Fatty acid-binding protein 4 (FABP4) and FABP5 modulate cytokine production in the mouse thymic epithelial cells.
5件表示
全件表示(24件)

■ 学会発表

1.	2020/12/05	トシリズマブが奏功したSchnitzler症候群の1例（口頭発表，一般）
2.	2020/12/04	The role of an adaptor protein SH3BP2 in the pathogenesis of systemic lupus erythematosus （ポスター，一般）
3.	2020/12/02	Deletion of Mir223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Fas lpr/lpr Mice （ポスター，一般）
4.	2020/11/05	Deletion of miR-223 exacerbates lupus nephritis by targeting S1pr1 in Faslpr/lpr mice （ポスター，一般）
5.	2020/10/24	Deletion of miR-223 exacerbates lupus nephritis by targeting S1pr1 in Faslpr/lpr mice （ポスター，一般）
6.	2020/10/15	miR223を介したS1PR1発現制御によるSLE病態への関与（ポスター，一般）
7.	2020/08/17	The reduction of S1pr1 by miR223-3p and their roles in the pathogenesis of SLE （ポスター，一般）
8.	2020/08/17	生物学的製剤治療を行った関節リウマチ患者における関節破壊の解析（ポスター，一般）
9.	2018/04/27	DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice. （口頭発表，一般）
10.	2017/12/13	DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice. （口頭発表，一般）
11.	2017/09/28	MRL/lprマウスにおけるDNAメチル化感受性転写因子KaisoによるカテプシンE (CTSE) の発現制御（ポスター，一般）
12.	2017/09/18	DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice. （口頭発表，一般）
13.	2017/04/21	DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice. （口頭発表，一般）
14.	2016/12/07	DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice. （口頭発表，一般）
15.	2016/05/07	多発脳神経麻痺をきたした結節性動脈炎の1例（口頭発表，一般）
16.	2016/04/21	Clinical course and treatment of two refractory cases of antiHMGCR antibody-associated necrotizing autoimmune myopathy （口頭発表，一般）
17.	2015/10/22	心筋障害を併発しリツキシマブが著効したTAFRO症候群の1例（ポスター，一般）
18.	2015/04/23	生物学的製剤を使用した関節リウマチ患者における抗CCP抗体, 抗mutated citrullinated vimentin 抗体, リウマトイド因子の変動に関する検討（口頭発表，一般）
19.	2014/12/06	難治性食道潰瘍を認めたBehcet病の3例（口頭発表，一般）
20.	2014/04/24	ANCA関連血管炎に対するミコフェノール酸モフェチルの有用性に関する検討（口頭発表，一般）
21.	2013/11/23	SLEに視神経脊髄炎を合併した1例（口頭発表，一般）
5件表示
全件表示(21件)

■ 所属学会

1.	2013/03～	日本内科学会
2.	2013/09～	日本リウマチ学会
3.	2021/04	∟ 評議員
4.	2015/06～	日本臨床免疫学会
5.	2016/02～	日本免疫学会
6.	2020/08～	日本分子生物学会
5件表示
全件表示(6件)

■ 受賞学術賞

1.	2013	平成25年度病院長賞「楷の木賞」
2.	2015	会長ポスター賞　症例報告部門　第43回日本臨床免疫学会総会2015 (心筋障害を併発したリツキシマブが著効したTAFRO症候群の１例)